ClinicalTrials.Veeva

Menu

Electrophysiological Mechanisms and Inhibitory Cardiac Syncope (ELICA)

U

University of Campania "Luigi Vanvitelli"

Status and phase

Completed
Phase 1

Conditions

Syncope Recurrent

Treatments

Device: pacemaker

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

OBJECTIVES: To evaluate syncope recurrence at follow up in patients with a positive cardio inhibitory response to the head up tilt testing (HUT) evaluation.

METHODS: 36 consecutive patients affected by cardio inhibitory syncope to HUT without asystolia (2A type) have been enrolled in this study. These patients have been studied by electrophysiological study (ES). After ES patients have been differently treated (interventional treatment group A, v/s drug therapy group), and followed up during 360 days, to evaluate syncope recurrences.

Enrollment

36 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age more than 18, normal heart function, more than 1 syncope event for year.

Exclusion criteria

  • age inferior 18 years, history of myocardial infarction, heart failure, structural heart disease.

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

36 participants in 2 patient groups

electrophysiological testing
Active Comparator group
Description:
Patients will receive a pacemaker.
Treatment:
Device: pacemaker
control group
No Intervention group
Description:
These subjects will receive cardicor® (beta blockers).

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems